−0.7591USD
−39.443MUSD
43.017M
About NuCana plc
Sector
Industry
CEO
Hugh Stephen Griffith
Website
Headquarters
Edinburgh
Founded
1997
ISIN
US67022C1062
NuCana Plc is a clinical stage biopharmaceutical company. It engages in the business of developing a portfolio of new medicines to treat patients with cancer. The company was founded by Hugh Stephen Griffith and Christopher Barry Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.
This NCNA Penny Stock Could Surge Over 300%, Say AnalystThis NCNA Penny Stock Could Surge Over 300%, Say Analyst
NuCana uses a phosphoramidate chemistry technology called ProTide to create a class of drugs that will surmount the limitations of the existing nucleotide analogs behind many chemotherapy drugs. NuCana’s ProTides have already been used in Gil
NCNA Bullish DivergenceLooking like a possible buy opportunity. Showing bullish divergence. I'm waiting for the stochastic RSI to cross 20 on the 3 day.
NuCana Announces FDA Clearance to Commence Phase III Study of AcNCNA: NuCana plc
2019-10-25 07:00:05
NuCana Announces FDA Clearance to Commence Phase III Study of Acelarin (NUC-1031) for the First-Line Treatment of Patients with Biliary Tract Cancer
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
